Ventilator Weaning Practices in Patients Intubated for Guillain-Barré Syndrome or Myasthenia Gravis
GUIMAUVE
1 other identifier
observational
800
1 country
1
Brief Summary
Guillain-Barré syndrome and myasthenia gravis are two neuromuscular diseases that are commonly managed in ICUs that may require different weaning protocols. To date, no study has compared weaning modalities from mechanical ventilation in patients with these two diseases. Our objective was to assess and compare for ventilator weaning modalities between patients mechanically ventilated for Guillain-Barré syndrome or for myasthenia gravis in a large-scale multicenter study.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Feb 2024
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 27, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 6, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
November 6, 2024
CompletedFirst Submitted
Initial submission to the registry
June 6, 2025
CompletedFirst Posted
Study publicly available on registry
June 15, 2025
CompletedJune 18, 2025
June 1, 2025
8 months
June 6, 2025
June 13, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
The proportion of patients with prolonged weaning
Prolonged weaning defined as still being under mechanical ventilation at least 7 days after the initial separation attempt from the ventilator
7 days after the initial separation attempt from the ventilator
Study Arms (1)
Patients mechanically ventilated for Guillain-Barré syndrome or for myasthenia gravis (two groups)
Eligibility Criteria
Patients intubated and mechanically ventilated in ICUs for Guillain-Barré syndrome or myasthenia gravis
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
CHU de POITIERS
Poitiers, 86000, France
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Arnaud W THILLE, MD, PhD
University Hospital of Poitiers
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
June 6, 2025
First Posted
June 15, 2025
Study Start
February 27, 2024
Primary Completion
November 6, 2024
Study Completion
November 6, 2024
Last Updated
June 18, 2025
Record last verified: 2025-06